We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

63 hedge funds and large institutions have $41.9M invested in Tempest Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,000% more call options, than puts

Call options by funds: $21K | Put options by funds: $1K

32% more capital invested

Capital invested by funds: $31.7M → $41.9M (+$10.2M)

24% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 17

25% less funds holding

Funds holding: 84 → 63 (-21)

63% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 24

Holders
63
Holders Change
-21
Holders Change %
-25%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
17
Closed
24
Calls
$21K
Puts
$1K
Net Calls
+$20K
Net Calls Change
+$58K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$5.59M
2
BlackRock
BlackRock
New York
+$2.98M
3
SM
Sabby Management
Florida
+$596K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$545K
5
GC
GMT Capital
Georgia
+$368K

Top Sellers

Rank Fund Capital Flow
1
CC
CQS Cayman
Cayman Islands
-$1.05M
2
PCM
Portolan Capital Management
Massachusetts
-$1.02M
3
AFM
Anson Funds Management
Texas
-$637K
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$331K
5
Northern Trust
Northern Trust
Illinois
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
76
Anson Funds Management
Texas
– -$637K -142 Closed
BCM
77
Bridgeway Capital Management
Texas
– -$282K -63 Closed
SSA
78
Schonfeld Strategic Advisors
New York
– -$153K -34 Closed
CS
79
Credit Suisse
Switzerland
– -$138K -31 Closed
Goldman Sachs
80
Goldman Sachs
New York
– -$121K -27 Closed
Jane Street
81
Jane Street
New York
– -$101K -23 Closed
ID
82
Integral Derivatives
New York
– -$86K -19 Closed
CA
83
Commerzbank Aktiengesellschaft
Germany
– -$63K -14 Closed
DTL
84
Dynamic Technology Lab
Singapore
– -$56K -13 Closed
PP
85
PDT Partners
New York
– -$57K -13 Closed
JHIU
86
Janus Henderson Investors US
Colorado
– -$47K -10 Closed
ZIM
87
Zacks Investment Management
Illinois
– -$36K -8 Closed
Squarepoint
88
Squarepoint
New York
– -$30K -7 Closed
PP
89
Paloma Partners
Connecticut
– -$25K -6 Closed
TC
90
TFS Capital
Pennsylvania
– -$27K -6 Closed
Group One Trading
91
Group One Trading
Illinois
– -$13K -3 Closed
CLOS
92
Compagnie Lombard Odier SCmA
Switzerland
– -$5K -1 Closed
TDC
93
Thompson Davis & Co
Virginia
– -$2K – –
1 2 3
4

TPST Hedge Fund Activity: Q1 2017 in Review

63 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2017, worth a combined $41.9M — up 32% from $31.7M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of TPST and 9 opened new positions — a net loss of 15 holders — while 17 trimmed existing stakes and 13 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $5.59M. The largest seller was CQS Cayman, exiting entirely with an estimated $1.05M sold.

  • 63 institutional investors held Tempest Therapeutics (TPST) as of Q1 2017, down from 84 in Q4 2016.
  • Funds reported $41.9M of Tempest Therapeutics stock for Q1 2017, up 32% quarter-over-quarter.
  • 9 funds opened new Tempest Therapeutics positions in Q1 2017 and 24 closed out, a net change of -15 holders.
  • The largest Tempest Therapeutics buyer in Q1 2017 was EcoR1 Capital, an estimated $5.59M added.
  • The largest Tempest Therapeutics seller in Q1 2017 was CQS Cayman, an estimated $1.05M sold.

Based on aggregated 13F filings for Q1 2017.